- Home
- PRLD vs NTIC Comparison
PRLD vs NTIC Comparison
Compare PRLD & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | NTIC |
|---|---|---|
| Founded | 2016 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 77.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRLD | NTIC |
|---|---|---|
| Price | $1.68 | $7.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 28.4K |
| Earning Date | 11-12-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $10,500,000.00 | ★ $84,234,474.00 |
| Revenue This Year | N/A | $7.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4,003.42 |
| Revenue Growth | ★ 250.00 | N/A |
| 52 Week Low | $0.61 | $6.75 |
| 52 Week High | $4.22 | $14.75 |
Technical Indicators
Market Signals| Indicator | PRLD | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 39.08 |
| Support Level | $1.32 | $7.38 |
| Resistance Level | $1.69 | $7.57 |
| Average True Range (ATR) | 0.17 | 0.18 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 91.02 | 8.38 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.